![](/img/cover-not-exists.png)
DNA flow cytometry measurements as surrogate endpoints in chemoprevention trials: Clinical, biological, and quality control considerations
Lynn G. DresslerVolume:
53
Year:
1993
Language:
english
Pages:
7
DOI:
10.1002/jcb.240531139
File:
PDF, 696 KB
english, 1993